tiprankstipranks
Atossa Therapeutics (ATOS)
NASDAQ:ATOS
US Market
ATOS
Atossa Therapeutics
RESEARCH TOOLSreports

Atossa Therapeutics (ATOS) Financial Statements

Compare
2,562 Followers

Atossa Therapeutics Financial Overview

Atossa Therapeutics's market cap is currently $40.56M. The company's EPS TTM is $-1.19; its P/E ratio is -2.19; Atossa Therapeutics is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is $-0.92. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -16.00K$ -17.00K$ -23.00K$ -8.00K$ -23.00K
Operating Income$ -37.14M$ -27.62M$ -31.38M$ -27.69M$ -20.52M
EBITDA$ -37.13M$ -27.60M$ -31.35M$ -27.68M$ -20.50M
Net Income$ -34.77M$ -25.50M$ -30.09M$ -26.96M$ -20.61M
Balance Sheet
Cash & Short-Term Investments$ 41.30M$ 71.08M$ 88.46M$ 110.89M$ 136.38M
Total Assets$ 47.61M$ 76.44M$ 96.25M$ 123.53M$ 141.26M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -41.30M$ -71.08M$ -88.46M$ -110.89M$ -136.38M
Total Liabilities$ 8.26M$ 4.97M$ 5.24M$ 5.57M$ 3.13M
Stockholders' Equity$ 39.35M$ 71.48M$ 91.02M$ 117.96M$ 138.14M
Cash Flow
Free Cash Flow$ -29.79M$ -21.05M$ -20.95M$ -20.79M$ -16.48M
Operating Cash Flow$ -29.76M$ -21.03M$ -20.94M$ -20.76M$ -16.47M
Investing Cash Flow$ -23.00K$ -19.00K$ -14.00K$ -4.73M$ -9.00K
Financing Cash Flow$ 0.00$ 3.67M$ -1.48M$ 0.00$ 113.30M
Currency in USD

Atossa Therapeutics Earnings and Revenue History

Income Statement >

Atossa Therapeutics Debt to Assets

Balance Sheet >

Atossa Therapeutics Cash Flow

Cash Flow >

Atossa Therapeutics Forecast EPS vs Actual EPS

Earnings >